We encourage companies
that project change



News & events

”la Caixa” leads a 1.6 million Euro round in Minoryx


• Minoryx is dedicated to treating rare or orphan diseases, focusing on those derived from congenital metabolic disorders, a group of diseases for which there are no treatments in the majority of cases and that in their most severe versions affect particularly aggressively in children and adolescents. • ”la Caixa” is leading this operation through the Caixa Innvierte BioMed II fund, joined by the Sanfilippo Foundation Switzerland.

Continue reading...

Other news See all news »